Evaluation of arteriovenous crossing sheathotomy for decompression of branch retinal vein occlusion

Avcı, Remzi; İnan, Ümit Übeyt; Kaderli, Berkant

doi:10.1038/sj.eye.6702633

Cited by 24 publications

(7 citation statements)

References 35 publications

(66 reference statements)

Supporting

Mentioning

Contrasting

Order By: Relevance

“…Until now, most studies of arteriovenous sheathotomy have been poorly designed and have failed to show a convincing improvement in outcomes of BRVO that would justify the risks of the surgical procedure [141,150]. In a study comparing the functional and anatomical outcomes of arteriovenous sheathotomy and intravitreal triamcinolone acetonide injection in the treatment of macular edema associated with BRVO, the patients showed similar functional and anatomical outcomes 6 months later.…”

Section: Surgical Approaches To Treating Rvomentioning

confidence: 99%

Management of Retinal Vein Occlusion – Consensus Document

et al. 2011

View full text Add to dashboard Cite

Retinal vein occlusion (RVO) can have severe consequences for the people affected by the disease, including visual loss with costly social repercussions. Currently, there is no European consensus with regard to the management of RVO. Following a careful review of the medical literature as well as the data from several clinical trials, a collaborative group of retina specialists put forth practical recommendations based on the best available scientific evidence for the clinical approach to RVO. Taking into consideration the recent advances in diagnostic tools and management options, the present document aims to provide the European ophthalmologists with guidelines for clinical practice to the benefit of their patients.

show abstract

Section: Surgical Approaches To Treating Rvomentioning

confidence: 99%

Management of Retinal Vein Occlusion – Consensus Document

et al. 2011

View full text Add to dashboard Cite

show abstract

“…Finally, the so called sheathotomy is also based on the idea of a mechanical compression and indeed, beneficial effects have been described in some studies [12–14]. …”

Section: Present Pathogenetic Conceptsmentioning

confidence: 99%

Retinal vein occlusions: The potential impact of a dysregulation of the retinal veins

2010

View full text Add to dashboard Cite

A retinal vein occlusion (RVO) is a sight threatening disease. It can be divided into central vein occlusion and branch retinal vein occlusion. The pathogenesis of the condition remains to be solved. Mechanical compression of the vessel wall or thrombotic occlusion of the vessel lumen, sometimes combined with rheological disorders, are often assumed pathomechanisms. Accordingly, the therapy relies either on mechanical decompression, lyses of thrombi or improvement of rheology. A number of observations however, such as the relationship of RVO to atherosclerotic risk factors, spontaneous reversibility particularly in young patients, rest flow observed in angiography, occlusion despite anticoagulation or thrombocytopenia and finally the positive effect of anti-VEGF therapy are not explained by the present pathogenetic concept. As a new concept we propose a local venous constriction induced by vasoconstrictive molecules diffusing from neighbouring diseased arteries and/or from other neighbouring (hypoxic) tissues. Recognizing these postulated conditions might lead to an earlier identification of impending vein occlusions as well as to a treatment more tailored to the risk factor constellation of the particular patient.

show abstract

“…Unfortunately, until now, most studies have failed to show a convincing improvement on outcomes in BRVO that could justify the risks of the surgical procedure [54, 55]. In conclusion, many different surgical treatments have been proposed but, to date, results remain inconsistent and controversial.…”

Section: Surgical Optionsmentioning

confidence: 99%

Practical Management of Retinal Vein Occlusions

Spina¹,

Benedetto²,

Parodi³

et al. 2012

Ophthalmol Ther

View full text Add to dashboard Cite

Retinal vein occlusion (RVO) is the second most common cause of visual impairment due to retinal disease after diabetic retinopathy. Nowadays, the introduction of new, powerful diagnostic tools, such as spectral domain optical coherence tomography, and the widespread diffusion of intravitreal drugs, such as vascular endothelial grow factor inhibitors or implantable steroids, have dramatically changed the management and prognosis of RVO. The authors aim to summarize and review the main clinical, diagnostic, and therapeutic aspects of this condition. The authors conducted a review of the most relevant clinical trials and observational studies published within the last 30 years using a keyword search of MEDLINE, EMBASE, Current Contents, and Cochrane Library. Furthermore, for all treatments discussed, the level of evidence supporting its use, as per the US Preventive Task Force Ranking System, is provided.

show abstract

Evaluation of arteriovenous crossing sheathotomy for decompression of branch retinal vein occlusion

Cited by 24 publications

References 35 publications

Management of Retinal Vein Occlusion – Consensus Document

Management of Retinal Vein Occlusion – Consensus Document

Retinal vein occlusions: The potential impact of a dysregulation of the retinal veins

Practical Management of Retinal Vein Occlusions

Contact Info

Product

Resources

About